The independent GLP-1 comparison site, 2026.
GLP Chart is the only US comparison site that scores every telehealth GLP-1 program against the same five criteria, re-checks prices every Monday against each program's published pricing, and takes zero paid placements. 25 programs scored. Updated June 5.
Most sites that call themselves a "GLP-1 comparison" are affiliate-funnel pages that list four or five programs the operator gets paid the most to recommend. We score every program in the US telehealth GLP-1 market on the same criteria and publish the methodology. The ranking is editorial. The chart is the data. Below: the five things a comparison site has to get right, what we do differently, and how we rank.
What a GLP-1 comparison site has to get right
- Same criteria for every program. If a program scores high on price but you cannot find the price column, the comparison is staged. We score pricing transparency, cancellation terms, onboarding, medication options, and member outcomes. Ten points each. Same rubric for all 25.
- Prices verified, not transcribed.Most comparison sites copy the headline price off the program homepage once. We read each program's published pricing pages for the maintenance-dose figure, not just the starter rate, and re-check every Monday against what each program publishes.
- Zero paid placements. The chart order is set before any money changes hands, and no program reviews our copy before publication.
- Independent of any program in the comparison. A comparison site that is owned by one of the programs it ranks is a sales channel, not a comparison.
- Visible methodology.If a site says "our rating is based on a proprietary algorithm", ask which factors and what weights. We publish ours. The five dimensions are equal weight. Sub-scores are visible on every program page.
What GLP Chart does differently
Three things that the established healthcare media properties (Healthline, GoodRx, Doctronic) do not.
- Published-price verification.We read each program's published pricing pages for the maintenance-dose figure, not just the headline starter rate, so the chart reflects what a program actually publishes rather than the most flattering teaser. When a program's site blocks automated access, we confirm the published number through a web search of its own materials.
- Weekly price checks. Prices change. Every Monday at 6 AM Central we re-check every program against its published pricing and publish what moved.
- Editorial defense. We are not a telehealth program, not a pharmacy, not a PBM. We do not enroll patients. We do not benefit from any specific program winning. We are paid by affiliate commissions on some outbound clicks.
How the GLP Chart ranking works
Each program is scored 0 to 10 on:
- Pricing transparency. Is the headline price the price you pay? Or is there a membership fee, dose escalation, or undisclosed add-on?
- Cancellation terms. Month-to-month, 90-day commitment, or 12-month lock-in? Cancellation friction, refund policy, and proration.
- Onboarding. Time to first dose, intake quality, doctor credentials, follow-up cadence.
- Medication options. Branded only, compounded only, or both? Which drugs and which doses?
- Member outcomes. Published outcomes data, drop-off rate, member satisfaction.
Total: 50 points. Composite score divided by 5 = the score out of 10 you see on the chart. Read the full methodology →
Who uses GLP Chart
Three audiences:
- Patients shopping for a program. The chart, by-medication shortcut, and condition pages are the primary entry. The 200-template prior authorization letter library serves the insurance-denied segment.
- Clinicians and journalists. The methodology, the Price Index, and the editorial pledge are the entry. Our work is cited in press; the newsroom is open.
- Researchers and policy analysts. The Price Index dataset is downloadable. The clinical trials directory at /trials/ mirrors ClinicalTrials.gov for the GLP-1 cohort.
Where to start
If you have not seen the ranking yet, the chart is the single answer. If you have a specific drug in mind, the by-medication shortcut beats the chart. If you have been denied insurance coverage, the PA letter library is the first stop.
- See the chart → (all 25 programs)
- GLP-1 program comparison chart → (every head-to-head, 25 programs)
- Cheapest by medication →
- PA letter library (200 templates) →
- Active GLP-1 clinical trials in the US →
- Side-effect probability calculator →
- How we score →
- Editorial independence →
Going deeper on one dimension? The pillar guides break each one down: the GLP-1 cost guide, the insurance and coverage guide, the side effects and safety guide, and the telehealth programs guide.
Other GLP-1 comparison sites
Several other sites publish GLP-1 program rankings. We track them for our own due diligence. Each has a different methodology, audience, and conflict-of-interest posture.
- GoodRx GLP-1 comparison. Tied to a pharmacy benefit aggregator. Prices reflect GoodRx discount cards, which is one route patients take. Methodology is not published.
- Healthline / RVO Health.Owned by Red Ventures + Optum (UnitedHealth's PBM parent). The site publishes good clinical explainers but the comparison rankings inherit the corporate-PBM conflict.
- Doctronic. AI explainer site. Comparison tables are LLM-generated and not re-verified weekly. Useful for a fast skim, not for a transaction decision.
- WeightWatchers Clinic. WW acquired the compounded-GLP-1 program Sequence in 2023. They are a program in the comparison, not an independent comparison.
- PeptideIQ. Compounded-peptide-focused affiliate site. Strong on dose ladders, weak on branded options.
We do not pretend to be the only source. We do claim to be the only independent source on this list.
